Terms ending in 2043
Every in-force patent on Hoffmann-La Roche Inc.'s record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,605,376 | Methods of Treating Relapsing Multiple Sclerosis Using an Inhibitor of Bruton's Tyrosine Kinase In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,596,120 | Ph-Gradient Spr-Based Binding Assay In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,565,536 | Method for Generating Avid-Binding Multispecific Antibodies In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,491,134 | Medical Delivery Device In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,654,144 | Process for the preparation of spray dried oligonucleotide products with controlled humidity In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,731,251 | Multi Arm Machine Learning Models with Attention for Lesion Segmentation In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,790,350 | Thiazolopyrimidinone Derivatives In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,570,615 | New Quinazolinone Derivatives In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,071,422 | Process for Synthesis of Quinazoline Compounds In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,791,420 | Microcapillary Holder, Test System and Process In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| 37 more term ends in 2043 · Pro | |||||
10 of 47 patents shown. Soonest term end first, then patent number.
Pro members see all 47.
46 of these are in force and held by Hoffmann-La Roche Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.